Cerus (STU:CU2) Institutional Ownership: 48.66% (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:CU2 Cerus Corp STU:CU2
78 GF Score
Price €2.34
GF Value €1.97
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Cerus Institutional Ownership?

Cerus STU:CU2 +0.86% 78 Institutional Ownership is 48.66% as of Aug. 27, 2026. GuruFocus rates STU:CU2 with a GF Score™ of 78/100 and a GF Value™ of €1.97 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cerus's institutional ownership is 48.66%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cerus's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cerus's Float Percentage Of Total Shares Outstanding is 97.11%.

Cerus Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Cerus's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cerus Institutional Ownership Chart

Cerus Historical Data

The historical data trend for Cerus can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 50.43 50.39 50.40 48.93 48.89 49.24 48.07 49.96 49.98 48.66
STU:CU2
78GF Score
Cerus Corp STU:CU2
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cerus Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 48.66% mean?
Cerus (STU:CU2) has a Institutional Ownership of 48.66% as of Aug. 27, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Cerus and its competitors.
Is Cerus' Institutional Ownership too high?
Cerus' current Institutional Ownership is 48.66%. Overall, Cerus has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cerus' Institutional Ownership compare to CTKB and TCMD?
Cerus' Institutional Ownership of 48.66% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Cerus and its competitors. Cerus's current Institutional Ownership is 48.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cerus stock overvalued right now?
Based on GuruFocus' analysis, Cerus (STU:CU2) is currently considered Modestly Overvalued. The stock's GF Value™ is €1.97, compared to a current price of €2.34 — trading 18.8% above its estimated fair value. The current Institutional Ownership is 48.66%. Cerus' overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Cerus (STU:CU2), the current Institutional Ownership is 48.66% as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cerus (STU:CU2) Overvalued in 2026?

Based on GuruFocus' analysis, Cerus stock appears to be overvalued. The current stock price of €2.34 is trading 18.8% above its estimated GF Value™ of €1.97. GuruFocus considers Cerus to be Modestly Overvalued.

Key valuation signals for STU:CU2:

  • Institutional Ownership: 48.66%
  • GF Value™: €1.97 vs. price of €2.34 (18.8% above fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the STU:CU2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cerus Business Description

Other Exchanges CERS:USA
Address 1220 Concord Avenue, Suite 600, Concord, CA, USA, 94520
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
78GF Score

Get the complete analysis for STU:CU2

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.34
Price
€1.97
GF Value